Cleo Bishop
Cleo received a PhD in Biological Sciences in 2001 from University College London. She then spent four years as a Career Development Fellow in the laboratory of Prof. Chris Higgins at the MRC Clinical Sciences Centre, Imperial College London, where she developed a keen interest in cancer biology.
In 2006, she moved to the Blizard Institute to pursue this, spending four years in Prof. David Beach’s group. During this time, she established our High-Throughput Screening facility, managed by Dr Luke Gammon, and has used this technology to discover novel regulators of the tumour suppressor p16.
In 2010, Cleo was awarded a Lectureship and continues her research into the regulation of the p16 and its role in senescence, cancer and ageing.
In 2006, she moved to the Blizard Institute to pursue this, spending four years in Prof. David Beach’s group. During this time, she established our High-Throughput Screening facility, managed by Dr Luke Gammon, and has used this technology to discover novel regulators of the tumour suppressor p16.
In 2010, Cleo was awarded a Lectureship and continues her research into the regulation of the p16 and its role in senescence, cancer and ageing.